Key result
Breastfeeding in women with peripartum cardiomyopathy was associated with elevated prolactin and CD8+ T cells, but did not impair myocardial recovery.
Why the study?
The etiology of peripartum cardiomyopathy remains unknown, and one hypothesis suggests breastfeeding may worsen the condition by increasing prolactin, alongside a proposed autoimmune etiology.
Does breastfeeding impair myocardial recovery in women with peripartum cardiomyopathy?
Observational
Does breastfeeding impair myocardial recovery in women with peripartum cardiomyopathy?
Answers are grounded in this paper and cite their sources.
Breastfeeding does not appear to impair myocardial recovery in women with peripartum cardiomyopathy, challenging the hypothesis that prolactin elevation from breastfeeding is detrimental.
The etiology of peripartum cardiomyopathy remains unknown. One hypothesis is that an increase in the 16-kDa form of prolactin is pathogenic and suggests that breastfeeding may worsen peripartum cardiomyopathy by increasing prolactin, while bromocriptine, which blocks prolactin release, may be therapeutic. An autoimmune etiology has also been proposed. The authors investigated the impact of breastfeeding on cellular immunity and myocardial recovery for women with peripartum cardiomyopathy in the IPAC (Investigations in Pregnancy Associated Cardiomyopathy) study. Women who breastfed had elevated prolactin, and prolactin levels correlated with elevations in CD8+ T cells. However, despite elevated prolactin and cytotoxic T cell subsets, myocardial recovery was not impaired in breastfeeding women.
No takes yet. Share an insight, caveat, or question.
Koczo et al. (2019) conducted an observational in Peripartum cardiomyopathy. Breastfeeding vs. No breastfeeding was evaluated on Myocardial recovery. Breastfeeding in women with peripartum cardiomyopathy was associated with elevated prolactin and CD8+ T cells, but did not impair myocardial recovery.
Synapse has enriched 10 related papers. Consider them for comparative context: